BAYN

AIVI · Weight increase · 2d

WisdomTree's AIVI, applying AI selection within its developed-international value-factor pool, initiated a consecutive weight increase in BAYN after the stock's allocation dipped significantly. This AI-managed fund, which periodically rebalances its portfolio of around 100 international developed-market value stocks, appears to have identified a compelling value entry point for Bayer AG, a Health Care sector company. The AI's models prompted an initial increase from 1.5448% on July 15th to 1.5460% on July 16th, followed by a more substantial rise to 1.5771% on July 17th. Such precise, AI-driven adjustments highlight AIVI's targeted approach to uncovering and capitalizing on specific valuation opportunities within the global value equity landscape.

weight 1.545% → 1.577% (+0.032 pp)

Jul 17·now $43.68

AIVI · Accumulation · 5d

BAYN shares, trading at levels approaching the lower quartile of their 52-week range following a period of modest returns, likely presented as an attractive candidate within AIVI's developed-international value-factor pool. The AI selection methodology employed by WisdomTree’s AIVI initiated a gradual accumulation of BAYER AG-REG, with the portfolio weight growing from 1.3097% on June 23rd to a peak of 1.8236% by July 2nd. This phased entry into the Health Care sector stock aligns with the ETF's periodic rebalancing approach, allowing the AI to build exposure as it continued to meet its quantitative value criteria in a comparatively underserved international value market segment.

weight 1.310% → 1.673% (+0.364 pp)

Jul 6·now $43.68

AIVI · Accumulation · 6d

The AIVI ETF exhibited a distinct pattern of gradual accumulation in BAYN, systematically increasing its weight from 1.2855% on June 22nd to 1.8236% by July 2nd, with several incremental adjustments punctuated by a larger single-day increase on June 25th. This measured pace aligns with AIVI’s strategy of periodic rebalancing, where its AI selection engine identifies developed-international value-factor opportunities such as the European Health Care firm BAYER AG-REG. The AI overlay likely perceived increasing value in BAYN at current levels, prompting a sustained allocation within its portfolio of around 100 international developed-market value stocks. Such calculated positioning reflects the fund’s commitment to an international value strategy, a comparatively underserved market corner where the AI aims to identify and capitalize on specific company metrics.

weight 1.286% → 1.824% (+0.538 pp)

Jul 2·now $43.68

AIVI · Accumulation · 6d

AIVI’s portfolio data reveals a sustained increase in its BAYER AG-REG allocation, moving from 1.2578% on June 18, 2026, to 1.7008% by July 1, 2026. This accumulation reflects WisdomTree's AI selection identifying BAYN as a fitting candidate within its developed-international value-factor pool. Observing this pattern, especially the significant daily jump on June 25th from 1.3444% to 1.6315%, the AI algorithm likely perceived a particularly favorable valuation point for the Health Care company’s shares. This measured accumulation aligns with AIVI's international value style, indicating the AI's conviction in BAYN's potential relative to its price, especially considering the ETF rebalances periodically rather than daily.

weight 1.258% → 1.701% (+0.443 pp)

Jul 1·now $43.68

AIVI · Accumulation · 6d

The weight-change pattern for BAYER AG-REG in AIVI reveals an initial gradual accumulation from 1.2228% to 1.3444% by June 24th, followed by a distinct step-up to 1.6315% on June 25th, and further incremental increases to 1.6758% by month-end. This cadence suggests WisdomTree's AI-driven method, focused on a developed-international value-factor pool, identified an opportune entry point for this healthcare stock. The AI's strategic build-up, combining measured initial accumulation with a subsequent significant increase, aligns with AIVI's periodic rebalancing schedule and its specialized approach in the comparatively underserved international value market.

weight 1.223% → 1.676% (+0.453 pp)

Jun 30·now $43.68

AIVI · Accumulation · 5d

For BAYER AG-REG, a Health Care sector company, the AIVI ETF displayed a pattern of gradual accumulation between June 15th and June 26th, 2026, suggesting its AI selection algorithms identified the stock as presenting value at its current trading levels. Starting at 1.2362% of the portfolio, the international developed-market stock's weight increased steadily through June 24th, reaching 1.3444%, before a more significant shift to 1.6315% on June 25th. This calculated accumulation reflects AIVI's method of AI selection within its developed-international value-factor pool, where the AI continuously evaluates opportunities for its portfolio of approximately 100 stocks. The observed weight adjustments align with the ETF's periodic rebalancing approach, rather than daily trading, allowing for a phased entry into positions based on the AI's ongoing assessment of value.

weight 1.236% → 1.622% (+0.386 pp)

Jun 26·now $43.68

AIVI · Accumulation · 5d

WisdomTree’s AIVI, which deploys an AI overlay to select its approximately 100 international developed-market value stocks, initiated a gradual accumulation of BAYN. Operating within its periodic rebalance framework, the AI selection method likely identified an increasing value proposition for BAYER AG-REG /EUR/ in the Health Care sector. The observed weight changes, escalating from 1.2425% to 1.6315% within a single week in June 2026, illustrate the AI's programmatic re-evaluation and subsequent phased increase of the position. This systematic approach is consistent with AIVI's focus on international value, a comparatively underserved corner of the ETF market.

weight 1.242% → 1.631% (+0.389 pp)

Jun 25·now $43.68

AIVI · Weight increase · 4d

As of mid-June 2026, Bayer AG shares were trading near the lower end of their 52-week range, having experienced a 20% decline from their prior year peak, yet showing signs of stabilization slightly above recent lows. Within AIVI's investment framework, which targets international developed-market value stocks through AI-driven selection, this price positioning likely flagged BAYN as a compelling candidate presenting a favorable risk-reward profile. The consecutive daily weight increases from 1.2578% on June 18th to 1.3444% by June 24th, following a period of minor reductions, indicate the AI's re-evaluation identified growing fundamental attractiveness or confirmed a positive shift in its valuation metrics for the healthcare firm. This incremental accumulation by the WisdomTree-managed fund, whose portfolio rebalances periodically rather than daily, highlights a sustained conviction by its AI engine regarding BAYN's value proposition within the approximately 100-stock international value universe.

weight 1.223% → 1.344% (+0.122 pp)

Jun 24·now $43.68

AIVI · Weight increase · 3d

The recent observed pattern for Bayer AG (BAYN) within AIVI reveals a series of gradual, consecutive weight increases, with its allocation rising from 1.2578% on June 18th to 1.3097% by June 23rd. This sustained accumulation of the Health Care sector firm aligns with AIVI’s AI-driven selection within the developed-international value-factor pool, suggesting the algorithm has identified an increasingly compelling valuation for BAYN. Operating within WisdomTree’s international value + AI overlay framework, these incremental additions to a portfolio of approximately 100 developed-market value stocks highlight the AI’s responsiveness in refining its conviction. Such a consistent upward adjustment indicates Bayer AG continually meets the criteria for increased weighting, specifically within this comparatively underserved corner of the international developed-market segment.

weight 1.223% → 1.310% (+0.087 pp)

Jun 23·now $43.68

AIVI · Weight increase · 2d

The weight for BAYN in AIVI registered consecutive increases on June 18th and 22nd, climbing from 1.2228% to 1.2855% over a brief trading interval. This series of upward adjustments suggests the fund's AI selection method identified improved value metrics for BAYER AG, a developed-market health care company, making it more attractive within AIVI's international value-factor pool. Despite AIVI's periodic, rather than daily, rebalancing approach, the AI's sustained accumulation indicates that BAYN's valuation profile at recent price points continued to align favorably with the fund's strategic overlay. This measured growth in allocation for a specific international value holding underscores the AI's ability to capitalize on perceived opportunities in a comparatively underserved segment of the ETF market.

weight 1.223% → 1.286% (+0.063 pp)

Jun 22·now $43.68

AIVI · Weight increase · 3d

Jun 5·now $43.68

AIVI · Weight increase · 2d

Jun 4·now $43.68

AIVI · Accumulation · 5d

May 7·entry $44.36·now $43.68Fresh

AIVI · Accumulation · 5d

May 6·entry $43.79·now $43.68Fresh

PQNT · Weight increase · 2d

Pictet Asset Management's PQNT, employing AI signals alongside factor exposures like fundamentals and momentum across its roughly 300 developed-market holdings, made a strategic adjustment to its Bayer AG position. The fund’s periodic rebalancing methodology, distinct from daily adjustments, enabled a significant increase in Bayer's weighting from 0.4400% on June 25th to 0.5900% by July 3rd. This upward trend suggests the AI models detected a sustained positive shift in the German Health Care company's underlying valuation, momentum, or sentiment profile. Such a deliberate allocation shift within its broad ex-US developed-market universe indicates a specific, reinforced conviction in Bayer's relative attractiveness.

weight 0.520% → 0.590% (+0.070 pp)

Jul 3·now $43.68

PQNT · Weight increase · 4d

PQNT, managed by Pictet Asset Management, initiated a series of purchases for BAYER AG-REG, increasing its allocation from a stable 0.4100% through June 22 to 0.5300% by June 28. This adjustment aligns with the fund's broad ex-US developed-market style, where AI signals integrate with fundamental, momentum, valuation, and sentiment factor exposures. The consecutive increases, beginning on June 24 and escalating significantly to 0.5300% on June 28, suggest the AI system detected accumulating positive indicators for BAYN within the Health Care sector. This pattern of growing conviction coincided with a period where the AI's models likely identified an increasingly favorable price-context for the stock, possibly reflecting strengthening momentum or an improved valuation signal. The fund's methodology, combining proprietary AI with established factor exposures, would have pinpointed BAYER AG's evolving profile as a suitable addition for increased weighting in the international portfolio during this specific timeframe.

weight 0.410% → 0.530% (+0.120 pp)

Jun 28·now $43.68

PQNT · Weight increase · 3d

The fund's allocation to BAYER AG-REG, a Health Care sector stock, exhibited a gradual, consecutive increase over three trading days in late June 2026, moving from 0.41% to 0.45% of the portfolio. This specific accumulation pattern suggests PQNT’s AI overlay, combined with its systematic multi-factor exposures, identified a strengthening investment case for the ex-US developed market company. While Pictet Asset Management's ETF rebalances periodically, not daily, the consistent adjustments from June 24th to 26th indicate the AI models detected favorable conditions or a reinforcing positive trend for BAYN, incrementally increasing its position at the prevailing price levels.

weight 0.410% → 0.450% (+0.040 pp)

Jun 26·now $43.68

PQNT · Weight increase · 2d

Trading near €35.50 on June 24th, BAYN, an ex-US developed market constituent, was positioned in the lower portion of its 52-week price range, having recently demonstrated a shift in its short-term trajectory following a period of consolidation. This setup aligns with PQNT's methodology, where its AI signals likely identified favorable valuation metrics and an improving short-term momentum trend for the Health Care sector company, drawing from its focus on fundamentals, momentum, valuation, and sentiment in ex-US markets. The fund, managed by Pictet Asset Management, appears to have weighted an improving sentiment alongside foundational fundamentals, prompting its system to allocate more capital. Consequently, PQNT increased BAYN's weight from 0.41% to 0.43% on June 24th, then further to 0.44% on June 25th, indicating a periodic portfolio adjustment reflecting these combined factor exposures.

weight 0.410% → 0.440% (+0.030 pp)

Jun 25·now $43.68